Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases (Q37214848)

19 August 2017

1 reference

title

Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases (English)

1 reference

inflammatory bowel diseases

19 August 2017

main subject

0 references

0 references

0 references

Charles Vanderpool

1

1 reference

19 August 2017

Fang Yan

series ordinal

2

1 reference

19 August 2017

D Brent Polk

series ordinal

3

1 reference

19 August 2017

publication date

1 November 2008

1 reference

Inflammatory Bowel Diseases

19 August 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

19 August 2017

volume

14

1 reference

19 August 2017

issue

11

1 reference

19 August 2017

page(s)

1585-1596

1 reference

PROBIOTICS: GROWTH-PROMOTING FACTORS PRODUCED BY MICROORGANISMS.

19 August 2017

cites work

1 reference

Commensal bacteria in the gut: learning who our friends are.

21 January 2018

1 reference

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression

21 January 2018

1 reference

Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells

21 January 2018

1 reference

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis

21 January 2018

1 reference

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

21 January 2018

1 reference

Lactobacillus GG in inducing and maintaining remission of Crohn's disease

21 January 2018

1 reference

A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease

21 January 2018

1 reference

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.

21 January 2018

1 reference

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

21 January 2018

1 reference

Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.

21 January 2018

1 reference

Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease.

21 January 2018

1 reference

Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease

21 January 2018

1 reference

Bacteriocins: developing innate immunity for food

21 January 2018

1 reference

Two-peptide lantibiotics: a medical perspective.

21 January 2018

1 reference

Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations

21 January 2018

1 reference

Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.

21 January 2018

1 reference

Comparative genomics of the lactic acid bacteria

21 January 2018

1 reference

The complete genome sequence of the meat-borne lactic acid bacterium Lactobacillus sakei 23K.

21 January 2018

1 reference

Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM

21 January 2018

1 reference

The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533

21 January 2018

1 reference

Kinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory compounds

21 January 2018

1 reference

Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid.

21 January 2018

1 reference

Real-time PCR quantification of bacterial adhesion to Caco-2 cells: competition between bifidobacteria and enteropathogens

21 January 2018

1 reference

Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements

21 January 2018

1 reference

Binding of Bifidobacterium bifidum and Lactobacillus reuteri to the carbohydrate moieties of intestinal glycolipids recognized by peanut agglutinin

21 January 2018

1 reference

Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea.

21 January 2018

1 reference

Immunology. Keeping the gut microflora at bay.

21 January 2018

1 reference

Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria

21 January 2018

1 reference

Faecal SIgA secretion in infants fed on pre- or probiotic infant formula

21 January 2018

1 reference

Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells

21 January 2018

1 reference

Bacterial probiotic modulation of dendritic cells

21 January 2018

1 reference

Modulation of human dendritic cell phenotype and function by probiotic bacteria

21 January 2018

1 reference

Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin

21 January 2018

1 reference

Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice

21 January 2018

1 reference

Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice.

21 January 2018

1 reference

Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism

21 January 2018

1 reference

G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages

21 January 2018

1 reference

Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling

21 January 2018

1 reference

An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system

21 January 2018

1 reference

Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization

21 January 2018

1 reference

DNA from probiotic bacteria modulates murine and human epithelial and immune function

21 January 2018

1 reference

CpG motifs: the active ingredient in bacterial extracts?

21 January 2018

1 reference

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

21 January 2018

1 reference

Toll-like receptor signaling and its relevance to intestinal inflammation

21 January 2018

1 reference

Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways

21 January 2018

1 reference

Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells

21 January 2018

1 reference

Human Toll-like receptor 4 recognizes host-specific LPS modifications.

21 January 2018

1 reference

The fundamental basis of inflammatory bowel disease

21 January 2018

1 reference

Unravelling the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair

21 January 2018

1 reference

Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism

21 January 2018

1 reference

Functional modulation of enterocytes by gram-positive and gram-negative microorganisms

21 January 2018

1 reference

Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells

21 January 2018

1 reference

Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells

21 January 2018

1 reference

NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.

21 January 2018

1 reference

Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.

21 January 2018

1 reference

Angiogenins: a new class of microbicidal proteins involved in innate immunity

21 January 2018

1 reference

Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells

21 January 2018

1 reference

Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth

21 January 2018

1 reference

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

21 January 2018

1 reference

Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression

21 January 2018

1 reference

Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius

21 January 2018

1 reference

Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.

21 January 2018

1 reference

Enterococcus faecalis from newborn babies regulate endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells

21 January 2018

1 reference

Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Synergistic enhancement of Toll-like receptor responses by NOD1 activation

21 January 2018

1 reference

Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus

21 January 2018

1 reference

VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

21 January 2018

1 reference

Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis

21 January 2018

1 reference

Epithelial NEMO links innate immunity to chronic intestinal inflammation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.20525

1 reference

19 August 2017

1 reference